MediWound Posts 65-Cent Quarterly Loss Per Share
MDWD sits 17% above its 52-week low of $11.8.
Summary
MediWound reported a third-quarter loss of $16.3M, or 65 cents per share, on revenue of $8.14M. The release carries no comparison to consensus and no year-over-year context, so the size of any miss or beat is unknown from this release alone. The loss lands two weeks after the company raised roughly $17.25 million gross through a bought deal of 1,380,000 shares at $12.50, cash that extends the runway while the company remains unprofitable. With the stock at $13.82 and a small-cap valuation, a per-share loss of this size keeps the focus on NexoBrid revenue ramp and burn rate rather than near-term profitability.
At the time of this announcement, MDWD was trading at $13.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $178.4M. The 52-week trading range was $11.80 to $19.70. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.